STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

February 21, 2025

Period of Report

February 19, 2025

Accession Number

0001062993-25-003241